179 related articles for article (PubMed ID: 2180518)
1. Theoretical and practical issues concerning the use of rhGM-CSF and rhIL-3: present status.
Jones TC
Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():36-7. PubMed ID: 2180518
[No Abstract] [Full Text] [Related]
2. Clinical role of granulocyte-macrophage colony-stimulating factor.
Mitsuyasu RT; Golde DW
Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
[TBL] [Abstract][Full Text] [Related]
3. [GM-CSF: its use in onco-hematologic diseases].
Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S
Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232
[No Abstract] [Full Text] [Related]
4. [GM-CSF: its clinical administration; the treatment of aplasia].
Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
[No Abstract] [Full Text] [Related]
5. [Application of CSF to cancer treatment].
Takaku F
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):739-46. PubMed ID: 2455478
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
[No Abstract] [Full Text] [Related]
7. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma.
Fay JW; Bernstein SH
Semin Oncol; 1996 Apr; 23(2 Suppl 4):22-7. PubMed ID: 8600545
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of autologous hematopoietic recovery by GM-CSF after allograft rejection.
Bandini G; Rosti G; Cavo M; Albertazzi L; Tura S
Haematologica; 1989; 74(6):627-8. PubMed ID: 2697676
[No Abstract] [Full Text] [Related]
9. Bone marrow failure and hematopoietic growth factors.
Douer D
Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
[No Abstract] [Full Text] [Related]
10. Clinical promise of new hematopoietic growth factors: M-CSF, IL-3, IL-6.
Garnick MB; O'Reilly RJ
Hematol Oncol Clin North Am; 1989 Sep; 3(3):495-509. PubMed ID: 2698879
[TBL] [Abstract][Full Text] [Related]
11. The use of growth factors in severe aplastic anaemia (SAA).
Hinterberger W; Hoffmann S; Bettelheim P; Geissler K; Maurer D; Muhm M
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():129-30. PubMed ID: 2697425
[No Abstract] [Full Text] [Related]
12. Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugs.
Krumwieh D; Schulz G; Seiler FR
Behring Inst Mitt; 1988 Apr; (82):265-81. PubMed ID: 2457362
[TBL] [Abstract][Full Text] [Related]
13. Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor.
Monroy RL; Skelly RR; Taylor P; Dubois A; Donahue RE; MacVittie TJ
Exp Hematol; 1988 Jun; 16(5):344-8. PubMed ID: 3286278
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
Schuening FG; Storb R; Goehle S; Nash R; Graham TC; Appelbaum FR; Hackman R; Sandmaier BM; Urdal DL
Exp Hematol; 1989 Sep; 17(8):889-94. PubMed ID: 2670596
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF and G-CSF in hematology and oncology.
Offner FC; Van Hove WZ
Acta Clin Belg; 1989; 44(5):318-25. PubMed ID: 2481926
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
Nissen-Druey C
Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852
[No Abstract] [Full Text] [Related]
18. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.
Hansen PB; Knudsen H; Gaarsdal E; Jensen L; Ralfkiaer E; Johnsen HE
Bone Marrow Transplant; 1995 Sep; 16(3):373-9. PubMed ID: 8535309
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte macrophage colony stimulating factor (GM-CSF) in AIDS.
Scadden DT
Prog Clin Biol Res; 1990; 338():163-76. PubMed ID: 2189138
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic growth factors in bone marrow transplantation for hematologic malignancies.
Lazarus HM
Prog Clin Biol Res; 1990; 352():531-8. PubMed ID: 1698303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
